127 related articles for article (PubMed ID: 16783830)
1. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors.
van der Putten L; de Bree R; Plukker JT; Langendijk JA; Smits C; Burlage FR; Leemans CR
Head Neck; 2006 Oct; 28(10):902-8. PubMed ID: 16783830
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
Lamers-Kuijper E; Schwarz M; Rasch C; Mijnheer B
Med Dosim; 2007; 32(4):237-45. PubMed ID: 17980823
[TBL] [Abstract][Full Text] [Related]
4. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
5. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
7. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
8. Temporal bone osteoradionecrosis after surgery and radiotherapy for malignant parotid tumors.
Leonetti JP; Marzo SJ; Zender CA; Porter RG; Melian E
Otol Neurotol; 2010 Jun; 31(4):656-9. PubMed ID: 20964249
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
[TBL] [Abstract][Full Text] [Related]
10. Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.
Jereczek-Fossa BA; Rondi E; Zarowski A; D'Onofrio A; Alterio D; Ciocca M; Bianchi LC; Krengli M; Calabrese L; Ansarin M; Giugliano G; Orecchia R
Strahlenther Onkol; 2011 Jun; 187(6):350-6. PubMed ID: 21603994
[TBL] [Abstract][Full Text] [Related]
11. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
Ortholan C; Chamorey E; Benezery K; Thariat J; Dassonville O; Poissonnet G; Bozec A; Follana P; Peyrade F; Sudaka A; Gerard JP; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):178-86. PubMed ID: 18565687
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
13. A prospective study on radiation-induced changes in hearing function.
Herrmann F; Dörr W; Müller R; Herrmann T
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1338-44. PubMed ID: 16863923
[TBL] [Abstract][Full Text] [Related]
14. Results of exploratory tympanotomy following sudden unilateral deafness and its effects on hearing restoration.
Maier W; Fradis M; Kimpel S; Schipper J; Laszig R
Ear Nose Throat J; 2008 Aug; 87(8):438-51. PubMed ID: 18712692
[TBL] [Abstract][Full Text] [Related]
15. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
16. Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005.
Bhide SA; Miah A; Barbachano Y; Harrington KJ; Newbold K; Nutting CM
Br J Oral Maxillofac Surg; 2009 Jun; 47(4):284-9. PubMed ID: 19193477
[TBL] [Abstract][Full Text] [Related]
17. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after parotid and temporal bone surgery for cancer.
Kwok HC; Morton RP; Chaplin JM; McIvor NP; Sillars HA
Laryngoscope; 2002 May; 112(5):820-33. PubMed ID: 12150613
[TBL] [Abstract][Full Text] [Related]
19. Radiation dose to otologic structures during head and neck cancer radiation therapy.
Ondrey FG; Greig JR; Herscher L
Laryngoscope; 2000 Feb; 110(2 Pt 1):217-21. PubMed ID: 10680919
[TBL] [Abstract][Full Text] [Related]
20. Elective parotidectomy in the management of advanced auricular malignancies.
Osborne RF; Shaw T; Zandifar H; Kraus D
Laryngoscope; 2008 Dec; 118(12):2139-45. PubMed ID: 19029866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
